0001104659-26-049485.txt : 20260427 0001104659-26-049485.hdr.sgml : 20260427 20260427164350 ACCESSION NUMBER: 0001104659-26-049485 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20260427 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 26901689 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 8-K 1 tm2612861d1_8k.htm FORM 8-K
false 0001069899 0001069899 2026-04-27 2026-04-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): April 27, 2026

 

Phibro Animal Health Corporation

(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)

 

Delaware   001-36410   13-1840497
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer Identification No.)

 

Glenpointe Centre East, 3rd Floor

300 Frank W. Burr Boulevard, Suite 21

Teaneck, New Jersey 07666-6712

(Address of Principal Executive Offices, including Zip Code)

 

(201) 329-7300

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share   PAHC   NASDAQ Stock Market

 

Check the appropriate box below if this Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

ITEM 7.01 REGULATION FD DISCLOSURE.

 

On April 27, 2026, Phibro Animal Health Corporation (the “Company”), issued a press release regarding Ordinance No. 1617, published on April 27, 2026 by the Brazilian Ministry of Agriculture and Livestock (MAPA), prohibiting the importation, manufacture, marketing and use of performance enhancing feed additives containing antimicrobials classified as important in human or veterinary medicine, including Phibro’s virginiamycin and bacitracin products. This prohibition will come into effect after a transition period of 180 days from the date of the Ordinance. During such transition period, companies and customers may continue to use and sell the products under their current labels. The Company has been actively engaged with MAPA on new registrations of virginiamycin for therapeutic use in cattle and broiler chickens, which are in the final stages of review and approval by MAPA and are expected during the transition period. The Company’s bacitracin product already carries therapeutic claims in Brazil. Based on the 180 day transition period, the Company expects the regulatory change to have limited impact on its fiscal year 2026 results. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information contained in this Item 7.01 and in the press release is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of, or otherwise regarded as filed under, the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

 

(d) Exhibits

 

Exhibit
Number		   Description
     
99.1   Press Release, dated April 27, 2026.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

PHIBRO ANIMAL HEALTH CORPORATION
 Registrant
Date: April 27, 2026 
  
 By: /s/ Judith Weinstein
 Name: Judith Weinstein
 Title: Senior Vice President, General Counsel and Corporate Secretary

 

 

 EX-99.1 2 tm2612861d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

 

 

For Immediate Release

 

Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials

 

TEANECK, N.J., April 27, 2026 (Business Wire) — Phibro Animal Health Corporation (Nasdaq: PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion indications.

 

The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27, 2026, prohibiting the importation, manufacture, marketing and use of performance enhancing feed additives containing antimicrobials classified as important in human or veterinary medicine, including virginiamycin and bacitracin. This regulation brings Brazil into alignment with regulatory approaches adopted in other global markets. This prohibition will come into effect after a transition period of 180 days from the date of the Ordinance, during such times companies and customers may continue to use and sell the products under their current labels.

 

Phibro is working cooperatively with MAPA and relevant industry associations to support an orderly transition. The Company has been actively engaged with MAPA on new registrations of virginiamycin for therapeutic use in cattle and broiler chickens. These registrations are in the final stages of review and approval by MAPA and are expected during the transition period.

 

Phibro’s bacitracin product already carries therapeutic claims in Brazil.

 

Under the new regulatory framework, following the transition period, use of the subject antimicrobials will require a veterinary prescription. To support compliance and operational efficiency, Phibro is making available to the Brazilian market PhibroVet®, a digital platform designed to facilitate the creation, transmission, and management of veterinary prescriptions and prescription history.

 

Based on the 180 day transition period, the Company expects the regulatory change to have limited impact on its fiscal year 2026 results. Additional information will be provided during the Company’s upcoming earnings call scheduled for May 7, 2026.

 

About Phibro Animal Health Corporation

 

Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. The Company strives to be a trusted partner to livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions that help maintain and enhance animal health. For more information, visit www.pahc.com.

 

1

 

 

 

Forward-Looking Statements

 

DISCLOSURE NOTICES

 

Forward-Looking Statements: This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this communication are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “outlook,” “potential,” “project,” “projection,” “plan,” “intend,” “seek,” “may,” “could,” “would,” “will,” “should,” “can,” “can have,” “likely,” the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. These statements are not guarantees of future performance or actions. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Phibro expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Quarterly Report on Form 10-Q and Annual Report on Form 10-K, including in the sections thereof captioned “Forward-Looking Statements” and “Risk Factors.” These filings and subsequent filings are available online at www.sec.gov, www.pahc.com, or on request from Phibro.

 

Internet Posting of Information: We routinely post information that may be important to investors in the “Investors” section of our website at www.pahc.com. We encourage investors and potential investors to consult our website regularly for important information about us.

 

Contact for Phibro Animal Health Corporation

Phibro Animal Health Corporation

Glenn C. David

Chief Financial Officer

+1-201-329-7300

or

investor.relations@pahc.com

 

2

 

 EX-101.SCH 3 pahc-20260427.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 pahc-20260427_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 pahc-20260427_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2612861d1_ex99-1img01.jpg GRAPHIC begin 644 tm2612861d1_ex99-1img01.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Cover
Apr. 27, 2026
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 27, 2026
Entity File Number 001-36410
Entity Registrant Name Phibro Animal Health Corporation
Entity Central Index Key 0001069899
Entity Tax Identification Number 13-1840497
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One Glenpointe Centre East, 3rd Floor
Entity Address, Address Line Two 300 Frank W. Burr Boulevard, Suite 21
Entity Address, City or Town Teaneck
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07666-6712
City Area Code 201
Local Phone Number 329-7300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, $0.0001 par value per share
Trading Symbol PAHC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 1 23 1 false 0 0 false 0 false false R1.htm 00000001 - Document - Cover Sheet http://pahc.com/role/Cover Cover Cover 1 false false All Reports Book All Reports pahc-20260427.xsd pahc-20260427_lab.xml pahc-20260427_pre.xml tm2612861d1_8k.htm http://xbrl.sec.gov/dei/2025 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2612861d1_8k.htm": { "nsprefix": "pahc", "nsuri": "http://pahc.com/20260427", "dts": { "schema": { "local": [ "pahc-20260427.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "labelLink": { "local": [ "pahc-20260427_lab.xml" ] }, "presentationLink": { "local": [ "pahc-20260427_pre.xml" ] }, "inline": { "local": [ "tm2612861d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2025": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2025": 23 }, "report": { "R1": { "role": "http://pahc.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2026-04-27", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2612861d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-04-27", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2612861d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentDescription", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AnnualInformationForm", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CountryRegion", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAccountingStandard", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAnnualReport", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodStartDate", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentQuarterlyReport", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentRegistrationStatement", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyReport", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine3", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityExTransitionPeriod", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPrimarySicNumber", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityVoluntaryFilers", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Extension", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NoTradingSymbolFlag", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12gTitle", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityReportingObligation", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://pahc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-26-049485-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-26-049485-xbrl.zip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end XML 16 tm2612861d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001069899 2026-04-27 2026-04-27 false 0001069899 8-K 2026-04-27 Phibro Animal Health Corporation DE 001-36410 13-1840497 Glenpointe Centre East, 3rd Floor 300 Frank W. Burr Boulevard, Suite 21 Teaneck NJ 07666-6712 201 329-7300 Class A Common Stock, $0.0001 par value per share PAHC NASDAQ false false false false false